9 Meters Biopharma Inc. [NASDAQ: NMTR] loss -0.12% or 0.0 points to close at $0.73 with a heavy trading volume of 2993911 shares.
It opened the trading session at $0.75, the shares rose to $0.7555 and dropped to $0.6771, the range by which the price of stock traded the whole day. The daily chart for NMTR points out that the company has recorded 53.10% gains over the past six months. However, it is still -97.3% lower than its most recent low trading price.
If we look at the average trading volume of 6.77M shares, NMTR reached to a volume of 2993911 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about 9 Meters Biopharma Inc. [NMTR]:
The Average True Range (ATR) for 9 Meters Biopharma Inc. is set at 0.09 The Price to Book ratio for the last quarter was 18.23, with the Price to Cash per share for the same quarter was set at 0.10.
Trading performance analysis for NMTR stock
9 Meters Biopharma Inc. [NMTR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.01. With this latest performance, NMTR shares gained by 9.98% in over the last four-week period, additionally plugging by 53.10% over the last 6 months – not to mention a drop of -31.21% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NMTR stock in for the last two-week period is set at 60.51, with the RSI for the last a single of trading hit 64.10, and the three-weeks RSI is set at 58.41 for 9 Meters Biopharma Inc. [NMTR]. The present Moving Average for the last 50 days of trading for this stock 0.5954, while it was recorded at 0.7000 for the last single week of trading.
9 Meters Biopharma Inc. [NMTR]: A deeper dive into fundamental analysis
9 Meters Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
9 Meters Biopharma Inc. [NMTR]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, 9 Meters Biopharma Inc. posted -0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.21/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 85.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NMTR.
An analysis of insider ownership at 9 Meters Biopharma Inc. [NMTR]
There are presently around $21 million, or 20.60% of NMTR stock, in the hands of institutional investors. The top three institutional holders of NMTR stocks are: ORBIMED ADVISORS LLC with ownership of 25,716,755, which is approximately New of the company’s market cap and around 1.00% of the total institutional ownership; GRANITE POINT CAPITAL MANAGEMENT, L.P., holding 1,087,026 shares of the stock with an approximate value of $0.79 million in NMTR stocks shares; and VANGUARD GROUP INC, currently with $0.52 million in NMTR stock with ownership of nearly -0.813% of the company’s market capitalization.
17 institutional holders increased their position in 9 Meters Biopharma Inc. [NASDAQ:NMTR] by around 27,243,087 shares. Additionally, 13 investors decreased positions by around 300,338 shares, while 4 investors held positions by with 1,083,103 shares. The mentioned changes placed institutional holdings at 28,626,528 shares, according to the latest SEC report filing. NMTR stock had 11 new institutional investments in for a total of 27,188,689 shares, while 9 institutional investors sold positions of 104,674 shares during the same period.